Recommended Pages at nasdaq.com
Allergan: Studies Show Botox Treats Overactive Bladder
nasdaq.com — “NASDAQ News: Allergan: Studies Show Botox Treats Overactive Bladder” View full resource at nasdaq.com
Most Recently Shared on March 28, 2012 at 2:20 pm By:
Allergan: Studies Show Botox Treats Overactive Bladder: Allergan: Studies Show Botox Treats Overactive Bladder http://t.co/6KjOWpCO
Economic Anxiety Continues Ahead Of Housing Data
nasdaq.com — “NASDAQ News: Economic Anxiety Continues Ahead Of Housing Data” View full resource at nasdaq.com
Most Recently Shared on March 23, 2012 at 7:12 pm By:
Economic Anxiety Continues Ahead Of Housing Data: Economic Anxiety Continues Ahead Of Housing Data http://t.co/n5Ye5oX6
Video: Dr. Eric Topol on the Effects of Tech on Medicine - NASDAQ.com
nasdaq.com — “NASDAQ Video - Dr. Eric Topol on the Effects of Tech on Medicine” View full resource at nasdaq.com
Most Recently Shared on March 22, 2012 at 11:06 pm By:
Eric Topol, MD Cardiologist, Physician, Doctor, and Internist
NASDAQ Home Page! Video: Dr. Eric Topol on the Effects of Tech on Medicine - http://t.co/PdXyLevG: http://t.co/Z3kULdBc via @AddThis #CDoM
FedEx's Smith: To Expand In Europe 'Primarily Through Organic Growth'
nasdaq.com — “NASDAQ News: FedEx's Smith: To Expand In Europe 'Primarily Through Organic Growth'” View full resource at nasdaq.com
Most Recently Shared on March 22, 2012 at 1:47 pm By:
FedEx's Smith: To Expand In Europe 'Primarily Through Organic Growth' http://t.co/JzIX4B8O
Abbott Selects AbbVie As New Name For Future Research-Based Pharma Co.
nasdaq.com — “NASDAQ News: Abbott Selects AbbVie As New Name For Future Research-Based Pharma Co.” View full resource at nasdaq.com
Most Recently Shared on March 21, 2012 at 2:33 pm By:
Abbvie. Interesting. http://t.co/zj5vG3Oa
FDA Panel Rejects Proposed Merck Cancer Drug For Sarcoma Patients
nasdaq.com — “NASDAQ News: FDA Panel Rejects Proposed Merck Cancer Drug For Sarcoma Patients” View full resource at nasdaq.com
Most Recently Shared on March 20, 2012 at 9:46 pm By:
FDA Panel Rejects Proposed Merck Cancer Drug For Sarcoma Patients: FDA Panel Rejects Proposed Merck Cancer Drug ... http://t.co/ZTW7ZLZe
Stella Pharma Says Health Canada Okays Cambia To Treat Acute Migraine
nasdaq.com — “NASDAQ News: Stella Pharma Says Health Canada Okays Cambia To Treat Acute Migraine” View full resource at nasdaq.com
Most Recently Shared on March 16, 2012 at 9:32 pm By:
Stella Pharma Says Health Canada Okays Cambia To Treat Acute Migraine: Stella Pharma Says Health Canada Okays Ca... http://t.co/eixrAkia
IBD/TIPP Economic Optimism Index Declined To 47.5 In March
nasdaq.com — “NASDAQ News: IBD/TIPP Economic Optimism Index Declined To 47.5 In March” View full resource at nasdaq.com
Most Recently Shared on March 13, 2012 at 7:35 pm By:
Inflammatory Bowel Syndrome OW Health
IBD/TIPP Economic Optimism Index Declined To 47.5 In March: IBD/TIPP Economic Optimism Index Declined To 47.5 In March http://t.co/RRIKp8z0
Hi-Tech Buys Homeopathic Branded Nasal Spray Products From Dynova Labs
nasdaq.com — “NASDAQ News: Hi-Tech Buys Homeopathic Branded Nasal Spray Products From Dynova Labs” View full resource at nasdaq.com
Most Recently Shared on March 8, 2012 at 6:57 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Hi-Tech Buys Homeopathic Branded Nasal Spray Products From Dynova Labs http://t.co/nTeq8T09
Drug Has No Long Term Help To African Americans With Light Smoking Habit
nasdaq.com — “NASDAQ News: Drug Has No Long Term Help To African Americans With Light Smoking Habit” View full resource at nasdaq.com
Most Recently Shared on March 6, 2012 at 11:37 pm By:
Drug Has No Long Term Help To African Americans With Light Smoking Habit: Drug Has No Long Term Help To African ... http://t.co/NoFyM9lr
A New Vision - Tackling TASS
nasdaq.com — “NASDAQ News: A New Vision - Tackling TASS” View full resource at nasdaq.com
Most Recently Shared on December 21, 2011 at 3:19 pm By:
A New Vision - Tackling TASS: (http://t.co/22yJJXgi) - In an effort to stem outbreaks of Toxic Anterior Segment S... http://t.co/Lg8fuf6M
Pfizer Says FDA Accepts For Review NDA For Tofacitinib For Rheumatoid Arthritis
nasdaq.com — “NASDAQ News: Pfizer Says FDA Accepts For Review NDA For Tofacitinib For Rheumatoid Arthritis” View full resource at nasdaq.com
Most Recently Shared on December 20, 2011 at 2:59 pm By:
Pfizer Says FDA Accepts For Review NDA For Tofacitinib For Rheumatoid Arthritis: Pfizer Says FDA Accepts For Rev... http://t.co/eYgysDq1
IBD/TIPP Economic Optimism Edges Up To 42.8 In December
nasdaq.com — “NASDAQ News: IBD/TIPP Economic Optimism Edges Up To 42.8 In December” View full resource at nasdaq.com
Most Recently Shared on December 13, 2011 at 8:21 pm By:
Inflammatory Bowel Syndrome OW Health
IBD/TIPP Economic Optimism Edges Up To 42.8 In December: IBD/TIPP Economic Optimism Edges Up To 42.8 In December http://t.co/bEtB9hKP
FDA Panel Recommends Use Of Alexza Pharma's Bipolar Treatment
nasdaq.com — “NASDAQ News: FDA Panel Recommends Use Of Alexza Pharma's Bipolar Treatment” View full resource at nasdaq.com
Most Recently Shared on December 13, 2011 at 2:25 pm By:
FDA Panel Recommends Use Of Alexza Pharma's Bipolar Treatment: FDA Panel Recommends Use Of Alexza Pharma's Bipol... http://t.co/SwKZ1BPh
Pfizer's Urinary Incontinence Drug Toviaz Meets Primary Point In Topline Study
nasdaq.com — “NASDAQ News: Pfizer's Urinary Incontinence Drug Toviaz Meets Primary Point In Topline Study” View full resource at nasdaq.com
Most Recently Shared on December 6, 2011 at 2:49 am By:
Pfizer's Urinary Incontinence Drug Toviaz Meets Primary Point In Topline Study: Pfizer's Urinary Incontinence Dr... http://t.co/NenjPjAV
